Recent months have seen a flood of stories about drug prices, from Martin Shkreli’s dramatic price hikes on generic drugs to Sovaldi's eye-watering introductory price. But woven within these stories are different storylines, each with its own set of complications and policy solutions. Here we present five distinct drug pricing storylines.
In caring for hospitalized patients with serious illnesses, clinicians and researchers often focus on death as the primary outcome to be avoided, but tend to pay less attention to other outcomes that may be equally or more unacceptable to some patients. We asked 180 patients hospitalized with serious illnesses to rate a series of health states on a 5 point Likert scale with options of worse than death, neither better nor worse than death, a little bit better than death, somewhat better than death, or much better than death. We report our findings in a research letter to JAMA Internal Medicine.
In a new paper in the European Journal of Public Health, Harkness Fellow Claudia Maier, and LDI Senior Fellow and Director of Penn Nursing’s Center for Health Outcomes and Policy Research Linda Aiken document the shifting of tasks that reflect expansion of nurses’ scope-of-practice in 39 countries. Their work shows that the current debates on scope-of-practice laws across US states have analogues in Europe, Canada, Australia, and New Zealand, as many countries seek to meet the primary care needs of their populations.
Following approval by the US Food and Drug Administration (FDA), subdermal probuphine will become the latest medication-assisted treatment (MAT) option to treat opioid use disorders in the United States. There are many advantages to probuphine, such as reducing the risk of medication diversion and increased medication adherence, but more research is needed to understand its cost-effectiveness and comparative effectiveness.
This chart on the educational debt level of medical school graduates was tucked away in supplementary material for an excellent article by Ari Friedman and colleagues in the Journal of General Internal Medicine on loan forgiveness programs.
How should social risk factors enter into Medicare’s value-based payments to hospitals? The answer goes beyond an arcane discussion of payment policy; it has a direct impact on hospital bottom lines and the quality of care provided to underserved communities. A new report from the National Academies of Sciences, Engineering, and Medicine—the third in a series of five—lays out criteria and methods to account for social risk factors in Medicare payment.
I just finished reading A Hand to Hold, a moving and powerful JAMA Piece of My Mind by LDI Senior Fellow Chris Feudtner. In it, he details his father’s last hours, and I was reminded of the end of my father’s journey just a few months ago, as I held his hand.
As health care costs increase, consumers are being asked to manage more of their own health care spending. One of the most common ways this is happening is through high deductible health insurance plans. Several years ago, my wife and I signed up for a high deductible health plan. It was a new offering from our employer and as two physicians we figured we were in a pretty good position to navigate the health care system. The system though, had a few surprises in store.
Over the three days that LDI hosted the 6th Biennial Conference of the American Society of Health Economists (June 12 - 15, 2016) we asked a few presenters to blog about their work, and their posts appear below. The authors were among the 1,000 health economists who gathered in Philadelphia to deliver more than 500 presentations and display more than 250 posters about the field's latest research.
Monday, June 13, 2016: 8:30 AM, G65 (Huntsman Hall) Tuesday, June 14, 2016: 10:15 AM-11:45 AM, 401 (Fisher-Bennett Hall)
Value-based payment reform is a hurricane tsunami that is sucking roosting chickens into a paradigm-shifting funnel of value-enhancing destructive innovation. Or it might not work. University of Michigan researchers are trying to find out. We explore the effects of value-based payment reform in several sessions at the 2016 ASHEcon meeting. Much of this research focuses on two specific programs: Hospital Value-Based Purchasing (HVBP) and the Hospital Readmission Reduction Program (HRRP). Both reforms were initiated by the ACA and link performance on indicators of quality and value to Medicare payments beginning in 2013 fiscal year.
Monday, June 13, 2016: 8:30 AM, Robertson Hall (Huntsman Hall)
In our paper, my colleagues and I were interested in examining how much the decision to expand Medicaid affected insurance coverage in the first year of the expansion. We used data from government surveys that have higher response rates than some private surveys to try to ensure that we were considering the impact of health care reform on all low-income adults. We found that the percentage uninsured fell by a substantial 6 percentage points in non-expansion states, although the decline was nearly double, about 11 percentage points, in expansion states. But we weren’t just interested in coverage. We also considered effects on access to health care and whether adults were going to the doctor.
Monday, June 13, 2016: 1:55 PM, G65 (Huntsman Hall)
In our paper, we analyze variation in premiums, choices, and enrollment from 2014-2016 on the Health Insurance Marketplaces (HIMs). The economic theory behind HIMs suggests that in a dynamic marketplace with many firms exiting and entering, competition will restrain premium growth. We find evidence of slower growth rates in total (pre-subsidy) premiums in highly populated rating areas as compared to less populated areas. In addition, pre-subsidy premiums were lower, all else equal, in areas where more firms were present in the marketplaces. The number of firms operating in rating areas dropped slightly in 2016 in all rating areas, but more rapidly in areas with lower population density. These results suggest that as HIMs continue to develop and mature, and if premiums are higher in areas with less competition among firms, then there will continue to be a differential in premiums that the ACA did not intend to maintain. Additional research on premium affordability in rural areas is needed, and ongoing monitoring of the competitiveness of rural HIMs is critical.
Monday, June 13, 2016: 10:15 AM, F50 (Huntsman Hall)
In the paper, “Regulating High-Skilled Immigration and the Market for Medical Residents”, authors Anthony Lo Sasso (U. Illinois-Chicago) and Michael Richards (Vanderbilt U.) explore the causes and consequences of teaching hospitals’ shift away from H1B visa-sponsored residency trainees toward US citizens that received their medical education abroad. They find a sharp change in residency programs’ preferences for H1B applicants during a period of stricter immigration rules. Their study also suggests that altering the composition of graduating physician cohorts is not without consequences – especially for provider availability in underserved areas.